Centhaquine (Centhaquin: PMZ-2010) is a novel agent has the potential for treatment of? haemorrhagic shock . Centhaquine (Centhaquin: PMZ-2010) can augment cardiac output, reduce?systemic vascular resistance in haemorrhagic models .
Centhaquine (Centhaquin: PMZ-2010) is a novel agent has the potential for treatment of? haemorrhagic shock . Centhaquine (Centhaquin: PMZ-2010) can augment cardiac output, reduce?systemic vascular resistance in haemorrhagic models .
Centhaquine (Centhaquin: PMZ-2010) is a novel agent has the potential for treatment of? haemorrhagic shock . Centhaquine (Centhaquin: PMZ-2010) can augment cardiac output, reduce?systemic vascular resistance in haemorrhagic models .
Centhaquine (Centhaquin: PMZ-2010) is a novel agent has the potential for treatment of? haemorrhagic shock . Centhaquine (Centhaquin: PMZ-2010) can augment cardiac output, reduce?systemic vascular resistance in haemorrhagic models .
Centhaquine (Centhaquin: PMZ-2010) is a novel agent has the potential for treatment of? haemorrhagic shock . Centhaquine (Centhaquin: PMZ-2010) can augment cardiac output, reduce?systemic vascular resistance in haemorrhagic models .
Centhaquine (Centhaquin: PMZ-2010) is a novel agent has the potential for treatment of? haemorrhagic shock . Centhaquine (Centhaquin: PMZ-2010) can augment cardiac output, reduce?systemic vascular resistance in haemorrhagic models .
Centhaquine (Centhaquin: PMZ-2010) is a novel agent has the potential for treatment of? haemorrhagic shock . Centhaquine (Centhaquin: PMZ-2010) can augment cardiac output, reduce?systemic vascular resistance in haemorrhagic models .
Centhaquine (Centhaquin: PMZ-2010) is a novel agent has the potential for treatment of? haemorrhagic shock . Centhaquine (Centhaquin: PMZ-2010) can augment cardiac output, reduce?systemic vascular resistance in haemorrhagic models .